PUOTI MASSIMO

Micheli, G., Mondi, A., Roen, A., Taramasso, L., Luchetti, I., Mazzotta, V., et al. (2026). Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 165(April 2026) [10.1016/j.ijid.2026.108437]. Dettaglio

Renisi, G., Comelli, A., Scudeller, L., Mazzone, A., Macaluso, G., Zanforlini, M., et al. (2026). Antimicrobial Stewardship (AMS) program in Lombardy region: analysis of effectiveness and costs. In Abstract Book 2026 36th Congress of the European Society of Clinical Microbiology and Infectious Diseases (pp.1-4). Dettaglio

Lapadula, G., Soria, A., Puoti, M., Bonfanti, P. (2026). Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV. AIDS, 40(8), 1053-1066 [10.1097/QAD.0000000000004511]. Dettaglio

Pipitò, L., Giacchino, I., Mazzola, C., Nicastri, E., Fasciana, T., Puoti, M., et al. (2026). Community-Acquired Pneumonia Outside the Intensive Care Unit: Clinical Characteristics and Impact of Rapid Molecular Diagnostics in the Italian SIS-NET Study. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 171(October 2026) [10.1016/j.ijid.2026.108988]. Dettaglio

Bana, N., Artelli, F., Lapadula, G., Bonfanti, P., Vitiello, P., Abeli, C., et al. (2026). Safety of cabotegravir + rilpivirine long-acting regimen among PLWH with previous HBV exposure: preliminary results of the SCRIBE study. In Abstracts from the 18th Italian Conference on AIDS and Antiviral Research (pp.92-94) [10.1136/sextrans-icar-2026.90]. Dettaglio